Could a simple polyp removal plus a drug replace major sinus surgery?
NCT ID NCT07200336
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for chronic sinusitis with nasal polyps: a less invasive surgery (simple polyp removal) combined with an anti-IL-5 drug (mepolizumab) versus extensive sinus surgery also with the drug. About 360 participants will be randomly assigned to one of three groups: drug alone, drug plus simple polyp removal, or drug plus extensive surgery. The goal is to see if the simpler approach works just as well, improving quality of life and nasal congestion over 1 to 3 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mepolizumab (anti-IL-5 drug)
- What this could lead to
- If successful, this could offer a less invasive treatment option for chronic sinusitis with nasal polyps, reducing the need for extensive surgery.
- What could go wrong
- This is a Phase 4 trial, but it's not yet recruiting. The less invasive approach may not be as effective as extensive surgery, and the drug may cause side effects like injection reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hangzhou First People's Hospital,School of Medicine, Westlake University
Hangzhou, Zhejiang, 310006, China
-
China-Japan Union Hospital of Jilin University
Changchun, Jilin, 130033, China
-
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, 200031, China
-
Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Shanghai, Shanghai Municipality, 200052, China
-
Longgang District Central Hospital of Shenzhen
Shenzhen, Guangdong, 518000, China
-
Renmin hospital of Wuhan University
Wuhan, Hubei, 430060, China
-
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200233, China
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266000, China
-
The Affiliated Hospital of Yunnan University
Kunming, Yunnan, 650000, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350005, China
-
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150001, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, 210029, China
-
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510000, China
-
The Second Hospital of Harbin Medical University
Harbin, Heilongjiang, 150086, China
-
The Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection shrink nasal polyps and restore easy breathing?
- Could a Pre-Surgery drug boost nasal polyp treatment?
- New study tests tezepelumab for chronic sinusitis sufferers
- 88% of patients with asthma and nasal polyps achieve dual remission on dupilumab
- Scientists probe the root cause of smell loss in chronic sinusitis
- Could a simple mucus test transform nasal polyp treatment?